Pace Ventures — Full Portfolio

Bitfount provides a federated AI and analytics platform that lets trial sponsors, CROs, clinics, hospitals and AI developers run algorithms on imaging and EHR data behind the firewall without extracting or sharing the data.

AI & Machine LearningDigital HealthHealthtech

PartnerMarius Swart· solo GP

Co-investorsSpeedinvestAhren Innovation Capital

Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE

Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel

PartnerMarius Swart· solo GP

Co-investorsFrontline VenturesY CombinatorSARAS CAPITALSpringboard Health Angels

ChemFinity develops advanced chemical separation technologies for recovering critical minerals and other resources.

CleantechDeep TechNew MaterialsBrooklyn, US

Adam Uliana(Executive Officer, Director)Ever Velasquez(Director)

PartnerMarius Swart· solo GP

Co-investorsAt One VenturesCreative Destruction Lab (CDL)

PartnerMarius Swart· solo GP

Co-investorsNext Gear Ventures

Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.

Biotech

Zahra Jawad(Founder)

PartnerMarius Swart· solo GP

Co-investorsBlueYard CapitalZAKA VCKdT Ventures

Dunia operates an autonomous materials acceleration platform called IRIS that combines robotics, AI foundation models, and experimental data to speed up the discovery of new materials, beginning with energy applications.

AI & Machine LearningDeep TechNew Materials

Marcus Tze-Kiat Ng(Founder)in

PartnerMarius Swart· solo GP

Co-investorsDeep Science VenturesElaiaKindred CapitalEICredalpine

FabricNano develops cell-free biocatalysis technology that immobilizes engineered enzymes onto scalable, environmentally friendly support materials for use in bio-processes.

BiotechCleantechNew MaterialsClaymont, US

Grant Aarons(Executive Officer, Director, Promoter)inFerdinando Randisi(Director)

BoardSiraj Khaliq(Director)inRobert Kniaz(Director)in

PartnerMarius Swart· solo GP

Co-investorsBackedEntrepreneur FirstHoxton VenturesAtomicoBoxOne Ventures

Holobiome discovers and develops therapies derived from the human gut microbiome, working to translate microbiome science into probiotics and targeted treatments for whole-body health.

AI & Machine LearningBiotechHealthtechLongevityBoston, US

Philip Strandwitz(Co-founder & Director, Chief Executive Officer)inKim Lewis(Co-founder, Director)Mike La Fleur(President, Co-founder, Director)Michael LaFleur(Executive Officer)

BoardJoan LaRovere(Director)inIain Chessell(Director)

PartnerMarius Swart· solo GP

Co-investorsAble PartnersBantam GroupHealthtech CapitaliSelect FundAlexandriaDeep Future+3 more

Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium.

BiotechFemTechHealthtech

Ashley Abel(Cofounder)Ashley Abel, Ph.D.(Founder)in

PartnerMarius Swart· solo GP

Co-investorsFifty YearsPillar VC

Neurable develops brain-computer interface (BCI) technology via smart headphones designed to enhance employee focus, productivity, and well-being in corporate settings.

AI & Machine LearningDeep TechHardwareHealthtechHR TechAnn Arbor, US

Dr. Ramses Alcaide(CEO and Co-Founder)Michael Thompson(Executive Officer)Adam Eizenberg-Molnar(Cofounder)

PartnerMarius Swart· solo GP

Co-investorsCapital FactoryFundersClubGlobal BrainGoAhead VenturesHartmann CapitalHouston Angel Network+9 more

PartnerMarius Swart· solo GP

Co-investorsBaruch Future VenturesPrelude VenturesVoyager Partners

Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment.

BiotechDigital HealthHealthtech

Sarah Blagden(Founder & CSO)

PartnerMarius Swart· solo GP

Co-investorsSie Ventures

Project Omega recycles spent nuclear fuel to rebuild the domestic nuclear fuel cycle, using chemistry processing to remove key isotopes and develop new products for the nuclear economy.

Deep TechDefense TechEnergy

Staff Sheehan(CEO)

PartnerMarius Swart· solo GP

Co-investorsGoAhead VenturesMantis CapitalStarship VenturesVirta Ventures

Ternary Therapeutics designs small molecule drugs called molecular glues using AI and physics-based modeling to enable protein interactions for treating diseases including cancer and arthritis.

AI & Machine LearningBiotechDeep Tech

PartnerMarius Swart· solo GP

Co-investorsUK Innovation & Science Seed Fund

Turnover Labs builds a durable electrolysis system that converts dilute CO2 emissions into pure, high-value chemical products on-site at any scale.

CleantechClimate TechNew Materials

Marissa Beatty(Founder & CEO)

PartnerMarius Swart· solo GP

Vema Hydrogen develops Engineered Mineral Hydrogen (EMH), a patented production method that stimulates naturally occurring subsurface geochemical reactions in ophiolite and BIF rock formations to produce carbon-free hydrogen at under $1/kg.

CleantechClimate TechEnergy

Pierre Levin(CEO)Colin McCulley(Director of Operations)

PartnerMarius Swart· solo GP

Co-investorsExtantia CapitalPropeller VC

Virtonomy builds v-Patients, a digital twin and simulation platform that lets medical device developers test devices in virtual patient cohorts based on real clinical data, covering products such as heart valves, stents, catheters, and occluders.

AI & Machine LearningDigital HealthMedical Devices

PartnerMarius Swart· solo GP

Co-investorsCompanistoDvH VenturesHoneystone VenturesAccenture VenturesBayern Kapital